Feasibility of NIH consensus criteria for chronic graft-versus-host disease

B-S Cho, C-K Min, K-S Eom, +8

Leukemia

Graft-versus-host DiseaseTransplantationGraft SurvivalGraft RejectionBlood Transplantation +3

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

Seung‐Hwan Lee, Dongwook Kim, B-S Cho, +12

Leukemia

Transplantation OutcomeHematological MalignancyTransplantationMedicineMixed-phenotype Acute Leukemia +8

Risk and prognostic factors for acute GVHD based on NIH consensus criteria

Se Lee, B-S Cho, Jae‐Hoon Kim, +13

Bone Marrow Transplantation

Prognostic FactorsPrognostic EvaluationDisease Risk AssessmentPrognosisPatient Safety +6

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

B-S Cho, C-K Min, K-S Eom, +9

Bone Marrow Transplantation

ThrombosisTransplantationMarrow TransplantationStem Cell TransplantationImmunology +10

Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation

C-K Min, S Y Kim, Matthew J. Lee, +10

Bone Marrow Transplantation

TransplantationAngiogenesisNonrelapse MortalityReduced SeverityStem Cell Transplantation +11

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study

B-S Cho, Sae-Mi Lee, YJ Kim, +9

Leukemia

Potential Therapeutic ApproachCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation +6

Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group

Ayami Yoshimi, Ritsuro Suzuki, Yoshiko Atsuta, +18

Bone Marrow Transplantation

TransplantationBlood TransfusionHematologyBlood CellHematopoietic Sct Activity +6

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation

Joo‐Heon Yoon, Hyung Jun Kim, Jae Woo Kim, +12

Bone Marrow Transplantation

TransplantationHematologyImmunologyPathologyMyeloid Neoplasia +5

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

Joo‐Heon Yoon, W-S Min, H.J. Kim, +13

Bone Marrow Transplantation

HepatologyHematopoietic SctHematologyGastroenterologySurgery +6

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia

SoJung Lee, Chung Ng, B-S Cho, +10

Leukemia

Hematological MalignancyTransplantationMarrow TransplantationMedicineMixed-phenotype Acute Leukemia +10